Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy
Objective: Little is known about seizures in natalizumab-associated progressive multifocal leukoencephalopathy (NAT-PML). Methods: A review of clinical records of 15 NAT-PML patients with multiple sclerosis (MS) treated at a German university hospital. Results: Some 53% (8/15) of our patients develo...
Main Authors: | Robert Hoepner, Stefanie Dahlhaus, Susanne Kollar, Barbara Zurawski, Andrew Chan, Ingo Kleiter, Ralf Gold, Kerstin Hellwig |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-01-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285613503515 |
Similar Items
-
Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions
by: Ruth Schneider, et al.
Published: (2017-09-01) -
Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
by: Julia Krämer, et al.
Published: (2017-01-01) -
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.
by: Molly R Perkins, et al.
Published: (2012-01-01) -
Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
by: Ruth Schneider, et al.
Published: (2017-01-01) -
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases
by: Robert Hoepner, et al.
Published: (2014-11-01)